Cargando…
TCMIP v2.0 Powers the Identification of Chemical Constituents Available in Xinglou Chengqi Decoction and the Exploration of Pharmacological Mechanisms Acting on Stroke Complicated With Tanre Fushi Syndrome
Xinglou Chengqi (XLCQ) decoction, composed of three botanical drugs and one inorganic drug, is used in clinics during the treatment of acute stroke complicated with Tanre Fushi (TRFS) syndrome in China. However, its active ingredients and the molecular mechanism have not been clarified. So, we aimed...
Autores principales: | Wang, Ping, Wang, Shuang, Chen, Hong, Deng, Xiaofang, Zhang, Luoqi, Xu, Haiyu, Yang, Hongjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8320350/ https://www.ncbi.nlm.nih.gov/pubmed/34335236 http://dx.doi.org/10.3389/fphar.2021.598200 |
Ejemplares similares
-
Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
por: Zhou, Shanshan, et al.
Publicado: (2020) -
The use of Xuanbai Chengqi decoction on monkeypox disease through the estrone-target AR interaction
por: Jiao, Yanqi, et al.
Publicado: (2023) -
An Integrative Pharmacology-Based Approach for Evaluating the Potential Effects of Purslane Seed in Diabetes Mellitus Treatment Using UHPLC-LTQ-Orbitrap and TCMIP V2.0
por: Hou, Jinli, et al.
Publicado: (2021) -
Chemical composition and therapeutic mechanism of Xuanbai Chengqi Decoction in the treatment of COVID-19 by network pharmacology, molecular docking and molecular dynamic analysis
por: Fan, Liming, et al.
Publicado: (2022) -
Effects of Chengqi Decoction on Complications and Prognosis of Patients with Pneumonia-Derived Sepsis: Retrospective Cohort Study
por: Huang, Zhipeng, et al.
Publicado: (2021)